• Beta Blocker Interruption in Patients With Prior MI: ABYSS Trial Results

  • Sep 17 2024
  • Length: 12 mins
  • Podcast

Beta Blocker Interruption in Patients With Prior MI: ABYSS Trial Results

Listen for free

View show details

  • Summary

  • The goal of the ABYSS (Assessment of Beta-Blocker Interruption 1 Year After an Uncomplicated Myocardial Infarction on Safety and Symptomatic Cardiac Events Requiring Hospitalization) trial was to evaluate beta-blocker interruption compared with beta-blocker continuation after an uncomplicated myocardial infarction (MI). Although the efficacy of beta blockers on decreasing mortality has diminished in the reperfusion era in patients without heart failure, this class of well tolerated drugs remain useful to decrease the rate of rehospitalization in patients who have suffered MI. In this interview, Drs. Deepak Bhatt and Johanne Silvain discuss the results of ABYSS and beta blocker interruption in patients with prior MI. References: Silvain J, Cayla G, Ferrari E, et al., for the ABYSS Investigators of the ACTION Study Group. Beta-Blocker Interruption or Continuation After Myocardial Infarction. N Engl J Med 2024;Aug 30:[Epub ahead of print]. Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
    Show more Show less
Show more Show less

What listeners say about Beta Blocker Interruption in Patients With Prior MI: ABYSS Trial Results

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available